Psychiatry Department, Inje University Ilsan Paik Hospital
Welcome,         Profile    Billing    Logout  
 5 Trials 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lee, Seung-Hwan
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Recruiting
3
12500
Europe, Canada, Japan, US, RoW
Lepodisiran Sodium, LY3819469, Placebo
Eli Lilly and Company
Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a)
03/29
03/29
ACHIEVE-4, NCT05803421: A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

Active, not recruiting
3
2749
Europe, US, RoW
Orforglipron, LY3502970, Insulin Glargine
Eli Lilly and Company
Type 2 Diabetes, Obesity, Overweight or Obesity, Overweight, Cardiovascular Diseases, Chronic Kidney Disease
09/25
01/26
NCT06712615: Phase II Study of PG-102(MG12) Compared with Placebo in Obesity and Type 2 Diabetes

Recruiting
2
144
RoW
PG-102, Placebo
ProGen. Co., Ltd.
Type 2 Diabetes Mellitus (T2DM), Obesity Type 2 Diabetes Mellitus
03/25
06/25
NEPTUNE-17, NCT05838755: A Study to Evaluate Efficacy and Safety of GSK3858279 in Diabetic Peripheral Neuropathic Pain

Terminated
2
147
Europe, Canada, Japan, US, RoW
GSK3858279, Placebo
GlaxoSmithKline
Pain
10/24
02/25
NCT06155487: A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Oral Administration of AJH-2947 in Healthy Korean and/or Caucasian Adult Male Subjects

Enrolling by invitation
1
68
RoW
AJH-2947 100 mg (SAD), Placebo, AJH-2947 200 mg (SAD), AJH-2947 300 mg (SAD), AJH-2947 400 mg (SAD), AJH-2947 600 mg (SAD), AJH-2947 800 mg (SAD), AJH-2947 200 mg (MAD), AJH-2947 400 mg (MAD), AJH-2947 600 mg (MAD)
JMackem Co., Ltd, Seoul National University Hospital
Neuropathic Pain, Diabetic Neuropathies, Post Herpetic Neuralgia
04/25
09/25
NCT03611725: Comparison of Success Rate Between Distal Radial Approach and Radial Approach in STEMI

Completed
N/A
352
RoW
Distal radial artery, Radial artery
Wonju Severance Christian Hospital, Hanmi Pharmaceutical co., ltd.
Distal Radial Artery Approach, ST Elevation Myocardial Infarction
03/23
12/23
GWPCI, NCT02038127: Gangwon PCI Prospective Registry

Recruiting
N/A
5000
RoW
Yonsei University, Gangwon Cardiovascular Health Research Institute
Coronary Artery Disease
12/30
12/31
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lee, Seung-Hwan
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Recruiting
3
12500
Europe, Canada, Japan, US, RoW
Lepodisiran Sodium, LY3819469, Placebo
Eli Lilly and Company
Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a)
03/29
03/29
ACHIEVE-4, NCT05803421: A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

Active, not recruiting
3
2749
Europe, US, RoW
Orforglipron, LY3502970, Insulin Glargine
Eli Lilly and Company
Type 2 Diabetes, Obesity, Overweight or Obesity, Overweight, Cardiovascular Diseases, Chronic Kidney Disease
09/25
01/26
NCT06712615: Phase II Study of PG-102(MG12) Compared with Placebo in Obesity and Type 2 Diabetes

Recruiting
2
144
RoW
PG-102, Placebo
ProGen. Co., Ltd.
Type 2 Diabetes Mellitus (T2DM), Obesity Type 2 Diabetes Mellitus
03/25
06/25
NEPTUNE-17, NCT05838755: A Study to Evaluate Efficacy and Safety of GSK3858279 in Diabetic Peripheral Neuropathic Pain

Terminated
2
147
Europe, Canada, Japan, US, RoW
GSK3858279, Placebo
GlaxoSmithKline
Pain
10/24
02/25
NCT06155487: A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Oral Administration of AJH-2947 in Healthy Korean and/or Caucasian Adult Male Subjects

Enrolling by invitation
1
68
RoW
AJH-2947 100 mg (SAD), Placebo, AJH-2947 200 mg (SAD), AJH-2947 300 mg (SAD), AJH-2947 400 mg (SAD), AJH-2947 600 mg (SAD), AJH-2947 800 mg (SAD), AJH-2947 200 mg (MAD), AJH-2947 400 mg (MAD), AJH-2947 600 mg (MAD)
JMackem Co., Ltd, Seoul National University Hospital
Neuropathic Pain, Diabetic Neuropathies, Post Herpetic Neuralgia
04/25
09/25
NCT03611725: Comparison of Success Rate Between Distal Radial Approach and Radial Approach in STEMI

Completed
N/A
352
RoW
Distal radial artery, Radial artery
Wonju Severance Christian Hospital, Hanmi Pharmaceutical co., ltd.
Distal Radial Artery Approach, ST Elevation Myocardial Infarction
03/23
12/23
GWPCI, NCT02038127: Gangwon PCI Prospective Registry

Recruiting
N/A
5000
RoW
Yonsei University, Gangwon Cardiovascular Health Research Institute
Coronary Artery Disease
12/30
12/31

Download Options